Cognitive and adaptive advantages of growth hormone treatment in children with Prader‐Willi syndrome
People with Prader‐Willi syndrome (PWS) typically have mild to moderate intellectual deficits, compulsivity, hyperphagia, obesity, and growth hormone deficiencies. Growth hormone treatment (GHT) in PWS has well‐established salutatory effects on linear growth and body composition, yet cognitive benefits of GHT, seen in other patient groups, have not been well studied in PWS.
No Supplementary Data
No Article Media